![Exploiting the Specificity of CRISPR/Cas System for Nucleic Acids Amplification-Free Disease Diagnostics in the Point-of-Care | Chem & Bio Engineering Exploiting the Specificity of CRISPR/Cas System for Nucleic Acids Amplification-Free Disease Diagnostics in the Point-of-Care | Chem & Bio Engineering](https://pubs.acs.org/cms/10.1021/cbe.3c00112/asset/images/medium/be3c00112_0004.gif)
Exploiting the Specificity of CRISPR/Cas System for Nucleic Acids Amplification-Free Disease Diagnostics in the Point-of-Care | Chem & Bio Engineering
![Unravelling the structural and mechanistic basis of CRISPR–Cas systems | Nature Reviews Microbiology Unravelling the structural and mechanistic basis of CRISPR–Cas systems | Nature Reviews Microbiology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnrmicro3279/MediaObjects/41579_2014_Article_BFnrmicro3279_Fig1_HTML.jpg)
Unravelling the structural and mechanistic basis of CRISPR–Cas systems | Nature Reviews Microbiology
![Application of different types of CRISPR/Cas-based systems in bacteria | Microbial Cell Factories | Full Text Application of different types of CRISPR/Cas-based systems in bacteria | Microbial Cell Factories | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12934-020-01431-z/MediaObjects/12934_2020_1431_Fig1_HTML.png)
Application of different types of CRISPR/Cas-based systems in bacteria | Microbial Cell Factories | Full Text
![Types of CRISPR-Cas systems (Part 22- CRISPR in gene editing and beyond) | by Roohi Bansal | Biotechnology by TSB | Medium Types of CRISPR-Cas systems (Part 22- CRISPR in gene editing and beyond) | by Roohi Bansal | Biotechnology by TSB | Medium](https://miro.medium.com/v2/resize:fit:1400/1*tmXBpZr-sszwlqvzEtIAXw.png)
Types of CRISPR-Cas systems (Part 22- CRISPR in gene editing and beyond) | by Roohi Bansal | Biotechnology by TSB | Medium
![Type III CRISPR-Cas systems can provide redundancy to counteract viral escape from type I systems | eLife Type III CRISPR-Cas systems can provide redundancy to counteract viral escape from type I systems | eLife](https://iiif.elifesciences.org/lax/27601%2Felife-27601-fig1-v4.tif/full/,1500/0/default.jpg)
Type III CRISPR-Cas systems can provide redundancy to counteract viral escape from type I systems | eLife
![Frontiers | Endogenous CRISPR-Cas System-Based Genome Editing and Antimicrobials: Review and Prospects Frontiers | Endogenous CRISPR-Cas System-Based Genome Editing and Antimicrobials: Review and Prospects](https://www.frontiersin.org/files/Articles/491504/fmicb-10-02471-HTML/image_m/fmicb-10-02471-g001.jpg)